References
- American Psychiatric Association. (2010). Practice guidelines for the treatment of patients with schizophrenia. 2nd Ed. Washington: A.P.A.
- Ardito, R., & Rabellino, D. (2011). Therapeutic alliance and outcome of psychotherapy: Historical excursus, measurements, and prospects for research. Frontiers in Psychology, 2, 270.
- Ashoorian, D., Davidson, R., Rock, D., Dragovic, M., & Clifford, R. (2015). A clinical communication tool for the assessment of psychotropic medication side effects. Psychiatry Research, 230(2), 643–657. https://doi.org/https://doi.org/10.1016/j.psychres.2015.10.022
- Bentall, R., Sousa, P., Varese, F., Wickham, S., Sitko, K., Haarmans, M., & Read, J. (2014). From adversity to psychosis: Pathways and mechanisms from specific adversities to specific symptoms. Social Psychiatry and Psychiatric Epidemiology, 49(7), 1011–1022.
- Bola, J. R., Kao, D., Soydan, H., & Adams, C. E. (2011). Antipsychotic medication for early episode schizophrenia. Cochrane Database of Systematic Reviews, 2011(6):CD006374. https://doi.org/https://doi.org/10.1002/14651858.CD006374.pub2
- Bola, J., Lehtinen, K., Cullberg, J., & Ciompi, L. (2009). Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first episode psychosis. Psychosis, 1(1), 4–18. https://doi.org/https://doi.org/10.1080/17522430802610008
- Calton, T., Ferriter, M., Huband, N., & Spandler, H. (2008). A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. Schizophrenia Bulletin, 34(1), 181–192.
- Ceraso, A., Lin, J. J., Schneider-Thoma, J., Siafis, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Davis, J. M., & Leucht, S. (2020). Maintenance treatment with antipsychotic drugs for schizophrenia. The Cochrane Database of Systematic Reviews, 118, CD008016.
- Cooke, A. (Ed.) (2017). Understanding psychosis and schizophrenia. British Psychological Society.
- Cooper, R., Grünwald, L., & Horowitz, M. (2020b). The case for including antipsychotics in the UK NICE guideline: “Medicines associated with dependence or withdrawal symptoms: Safe prescribing and withdrawal management for adults.” Psychosis, 12(1), 89–93. https://doi.org/https://doi.org/10.1080/17522439.2020.1722734
- Cooper, R., Laxhman, N., Crellin, N., Moncrieff, J., & Priebe, S. (2020a). Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review. Schizophrenia Research, 225, 15–30. https://doi.org/https://doi.org/10.1016/j.schres.2019.05.020
- Cooper, R., Mason, J., Calton, T., Richardson, J., & Moncrieff, J. (2021). The case for establishing a minimal medication alternative for people with psychosis and schizophrenia. Psychosis, 13(3), 276–285. https://doi.org/https://doi.org/10.1080/17522439.2021.1930119
- Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111–121. https://doi.org/https://doi.org/10.1016/j.addbeh.2018.08.027
- Day, J. C., Bentall, R. P., Roberts, C., Randall, F., Rogers, A., Cattell, D., Healy, D., Rae, P., & Power, C. (2005). Attitudes towards antipsychotic medication: The impact of clinical variables and relationships with health professionals. Archives of General Psychiatry, 62(7), 717–724. https://doi.org/https://doi.org/10.1001/archpsyc.62.7.717
- Francey, S. M., O’Donoghue, B., Nelson, B., Graham, J., Baldwin, L., Yuen, H. P., Kerr, M. J., Ratheesh, A., Allott, K., Alvarez-Jimenez, M., Fornito, A., Harrigan, S., Thompson, A. D., Wood, S., Berk, M., & McGorry, P. D. (2020). Psychosocial intervention with or without antipsychotic medication for first episode psychosis: A randomized noninferiority clinical trial. Schizophrenia Bulletin Open, 1(1), sgaa015, https://doi.org/https://doi.org/10.1093/schizbullopen/sgaa015
- Goldsmith, L., Lewis, S., Dunn, G., & Bentall, R. (2015). Psychological treatments for early psychosis can be beneficial or harmful, depending on the therapeutic alliance: An instrumental variable analysis. Psychological Medicine, 45(11), 2365–2373. https://doi.org/https://doi.org/10.1017/S003329171500032X
- Gray, R., Rofail, D., Allen, J., & Newey, T. (2005). A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. Journal of Advanced Nursing, 52(1), 31–37. https://doi.org/https://doi.org/10.1111/j.1365-2648.2005.03561.x
- Guy, A., Davies, J., & Rizq, R(Eds). (2019). Guidance for psychological therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs. All Party Parliamentary Group for Prescribed Drug Dependence.
- Ho, B., Andreasen, N., Ziebell, S., Pierson, R., & Magnotta, V. (2011). Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Archives of General Psychiatry, 68(2), 128–137. https://doi.org/https://doi.org/10.1001/archgenpsychiatry.2010.199
- Hornstein, G., Putnam, E., & Branitsky, A. (2020). How do hearing voices peer-support groups work? A three-phase model of transformation. Psychosis, 12(3), 201–211. https://doi.org/https://doi.org/10.1080/17522439.2020.1749876
- Horowitz, M., Jauhar, S., Natesan, S., Murray, R., & Taylor, D. (2021). A method for tapering antipsychotic treatment that may minimize the risk of relapse. Schizophrenia Bulletin, 47(4), 1116–1129. https://doi.org/https://doi.org/10.1093/schbul/sbab017
- Hurley, J., Jolley, S., Gibbons, O., Williams, A., Nath Varma, S., Bhandari, S., Mukherjee, K., Garraway, H., Jones, C., Aker, N., Appiah-Kusi, E., & Weaver, T. (2021). A five-year prospective evaluation of a new community psychosis service in North London: Introducing the Recovery and Enablement Track (RET). Psychosis, 13(1), 1–12. https://doi.org/https://doi.org/10.1080/17522439.2020.1803954
- Hutton, P., Weinmann, S., Bola, J., & Read, J. (2013). Antipsychotic drugs. In. Read, J., Dillon, J. (Eds.), Models of madness: Psychological, social and biological approaches to psychosis. Routledge: London. pp. 105–124.
- Jung, E., Wiesjahn, M., Wendt, H., Bock, T., Rief, W., & Lincoln, T. (2016). Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: A comparative interview study. Psychological Medicine, 46(10), 2179–2188. https://doi.org/https://doi.org/10.1017/S0033291716000775
- Kirsch, I. (2019). Placebo effect in the treatment of depression and anxiety. Frontiers in Psychiatry, 10, 407. https://doi.org/https://doi.org/10.3389/fpsyt.2019.00407
- Larsen-Barr, M., & Seymour, F. (2021). Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication. Therapeutic Advances in Psychopharmacology, 11, 1–16. https://doi.org/https://doi.org/10.1177/2045125321989133
- Larsen-Barr, M., Seymour, F., Read, J., & Gibson, K. (2018). Attempting to stop antipsychotic medication: Success, supports and efforts to cope. Social Psychiatry and Psychiatric Epidemiology, 53(7), 745–756.
- Lepping, P., Sambhi, R., Whittington, R., Lane, S., & Poole, R. (2011). Clinical relevance of findings in trials of antipsychotics: Systematic review. British Journal of Psychiatry, 198(5), 341–345. https://doi.org/https://doi.org/10.1192/bjp.bp.109.075366
- Leucht, S., Arbter, D., Engel, R., Kissling, W., & Davis, J. (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14(4), 429–447. https://doi.org/https://doi.org/10.1038/sj.mp.4002136
- Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Samara, M., Rabaioli, M., Bächer, S., Cipriani, A., Geddes, J., Salanti, G., & Davis, J. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. The American Journal of Psychiatry, 174(10), 927–942. https://doi.org/https://doi.org/10.1176/appi.ajp.2017.16121358
- Longden, E., & Read, J. (2016a). Assessing and reporting the adverse effects of antipsychotic medication: A systematic review of clinical studies, and prospective, retrospective, and cross-sectional research. Clinical Neuropharmacology, 39(1), 29–39. https://doi.org/https://doi.org/10.1097/WNF.0000000000000117
- Longden, E., & Read, J. (2016b). Social adversity in the etiology of psychosis: A review of the evidence. American Journal of Psychotherapy, 70(1), 5–33. https://doi.org/https://doi.org/10.1176/appi.psychotherapy.2016.70.1.5
- Longden, E., Read, J., & Dillon, J. (2018). Assessing the impact and effectiveness of hearing voices network self-help groups. Community Mental Health Journal, 54(2), 184–188. https://doi.org/https://doi.org/10.1007/s10597-017-0148-1
- Marston, L., Nazareth, I., Petersen, I., Walters, K., & Osborn, D. (2014). Prescribing of antipsychotics in UK primary care: A cohort study. BMJ Open, 4(12), e006135. https://doi.org/https://doi.org/10.1136/bmjopen-2014-006135
- Miller, D., Caroff, S., Davis, S., Rosenheck, R., McEvoy, J., Saltz, B., Riggio, S., Chakos, M., Swartz, M., Keefe, R., Stroup, T., & Lieberman, J. (2008). Extrapyramidal side-effects of antipsychotics in a randomised trial. British Journal of Psychiatry, 193(4), 279–288. https://doi.org/https://doi.org/10.1192/bjp.bp.108.050088
- Moncrieff, J. (2013). The bitterest pills: The troubling story of antipsychotic drugs. Palgrave.
- Moncrieff, J. (2015). Antipsychotic maintenance treatment: Time to rethink? PLOS Medicine, 12(8), e1001861. https://doi.org/https://doi.org/10.1371/journal.pmed.1001861
- Moncrieff, J., Cohen, D., & Mason, J. (2009). The subjective experience of taking antipsychotic medication: A content analysis of Internet data. Acta Psychiatrica Scandinavica, 120(2), 102–111. https://doi.org/https://doi.org/10.1111/j.1600-0447.2009.01356.x
- Moncrieff, J., Gupta, S., & Horowitz, M. A. (2020). Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder. Therapeutic Advances in Psychopharmacology, 10, 2045125320937910. https://doi.org/https://doi.org/10.1177/2045125320937910
- Morant, N., Azam, K., Johnson, S., & Moncrieff, J. (2018). The least worst option: User experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health, 27(4), 322–328. https://doi.org/https://doi.org/10.1080/09638237.2017.1370637
- Morrison, A. P., Turkington, D., Pyle, M., Spencer, H., Brabban, A., Dunn, G., Christodoulides, T., Dudley, R., Chapman, N., Callcott, P., Grace, T., Lumley, V., Drage, L., Tully, S., Irving, K., Cummings, A., Byrne, R., Davies, L. M., & Hutton, P. (2018). Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: A single-blind randomised controlled trial. The Lancet, 383(9926), 1395–1403. https://doi.org/https://doi.org/10.1016/S0140-6736(13)62246-1
- National Institute for Health and Care Excellence (2015). Psychosis and schizophrenia in adults: Quality Standard. NICE.
- Nelson, B., Torregrossa, L., Thompson, A., Sass, L., Park, S., Hartmann, J., McGorry, P., & Alvarez-Jimenez, M. (2021). Improving treatments for psychotic disorders: Beyond cognitive behaviour therapy for psychosis. Psychosis, 13(1), 78–84. https://doi.org/https://doi.org/10.1080/17522439.2020.1742200
- Priebe, S., Conneely, M., McCabe, R., & Bird, V. (2020). What can clinicians do to improve outcomes across psychiatric treatments: A conceptual review of non-specific components. Epidemiology and Psychiatric Sciences, 29, 1–8. https://doi.org/https://doi.org/10.1017/S2045796019000428
- Prytherch, H., Cooke, A., & Marsh, I. (2021). Coercion or collaboration: Service-user experiences of risk management in hospital and a trauma-informed crisis house. Psychosis, 13(2), 93–104. https://doi.org/https://doi.org/10.1080/17522439.2020.1830155
- Read, J. (2013). Biological psychiatry’s lost cause: The ‘schizophrenic’ brain. In Read, J., Dillon, J. (Eds), Models of madness. Routledge. pp. 72–89.
- Read, J. (2019). Making sense of, and responding sensibly to, psychosis. Journal of Humanistic Psychology, 59(5), 672–680. https://doi.org/https://doi.org/10.1177/0022167818761918
- Read, J. (2020a). How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients. Addictive Behaviors, 102, 106157. https://doi.org/https://doi.org/10.1016/j.addbeh.2019.106157
- Read, J. (2020b). Bad things happen and can drive you crazy: The causal beliefs of 701 people taking antipsychotics. Psychiatry Research, 285, 112754. https://doi.org/https://doi.org/10.1016/j.psychres.2020.112754
- Read, J. (2021). Withdrawal effects of antipsychotic drugs are still ignored. Psychol. Today, April 26. https://www.psychologytoday.com/ca/node/1160977/preview
- Read, J. (2022). The experiences of 585 people when they tried to come off antipsychotic drugs. Addictive Behaviors Reports, https://doi.org/https://doi.org/10.1016/j.abrep.2022.100421
- Read, J., Cartwright, C., Gibson, K., Shiels, C., & Haslam, N. (2014). Beliefs of people taking antidepressants about causes of depression and reasons for increased prescribing rates. Journal of Affective Disorders, 168, 236–242. https://doi.org/https://doi.org/10.1016/j.jad.2014.06.010
- Read, J., Davies, J., Montagu, L., Spada, M., & Frederick, B. (2019b). What do we know about withdrawal?. In: Guy, A., Davies, J., & Rizq, R. (Eds), Guidance for psychological therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs. All Party Parliamentary Group for Prescribed Drug Dependence. pp. 72–91.
- Read, J., & Dillon, J., (Eds.) (2013). Models of madness psychological, social and biological approaches to psychosis. London.
- Read, J., Gee, A., Diggle, J., & Butler, H. (2019a). Staying on, and coming off, antidepressants: The experiences of 752 UK adults. Addictive Behaviors, 88, 82–85. https://doi.org/https://doi.org/10.1016/j.addbeh.2018.08.021
- Read, J., Gibson, K., & Cartwright, C. (2016). Do GPs and psychiatrists recommend alternatives when prescribing anti-depressants? Psychiatry Research, 246, 838–840.
- Read, J., Gibson, K., & Cartwright, C. (2020). Are antidepressants overprescribed? Patients’ experiences of the prescribing process. Ethical Human Psychology and Psychiatry, 22(2), 83–97. https://doi.org/https://doi.org/10.1891/EHPP-D-20-00006
- Read, J., Gibson, K., Cartwright, C., Shiels, C., Dowrick, C., & Gabbay, M. (2015). Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants. Acta Psychiatrica Scandinavica, 131(6), 434–445.
- Read, J., Magliano, L., & Beavan, V. (2013). Public beliefs about the causes of ‘schizophrenia’: Bad things happen and can drive you crazy. In Read, J., Dillon, J., (Eds.), Models of madness. Routledge. pp. 141–156
- Read, J., Morrison, A., & Waddingham, R. (2020). Traumas, adversities, and psychosis: practical implications. Psychiatric Times, XXXVII, 48–51.
- Read, J., & Sacia, A. (2020). Using open questions to understand 650 people’s experiences with antipsychotic drugs. Schizophrenia Bulletin, 46(4), 896–604.
- Read, J., & Williams, J. (2018). Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects. Current Drug Safety, 13(3), 176–186.
- Read, J., & Williams, J. (2019). Positive and negative effects of antipsychotic medication: An international online survey of 832 recipients. Current Drug Safety, 14(3), 173–181. https://doi.org/https://doi.org/10.2174/1574886314666190301152734
- Ridenour, J., Hamm, J., & Czaja, M. (2019). A review of psychotherapeutic models and treatment for psychosis. Psychosis, 11(3), 248–260. https://doi.org/https://doi.org/10.1080/17522439.2019.1615111
- Shattock, L., Berry, K., Degnan, A., & Edge, D. (2018). Therapeutic alliance in psychological therapy for people with schizophrenia and related psychoses: A systematic review. Clinical Psychology & Psychotherapy, 25(1), e60–e85.
- Shevlin, M., Murphy, J., Read, J., Mallett, J., Adamson, G., & Houston, J. (2011). Childhood adversity and psychotic hallucinations: A community based study using the National Comorbidity Survey Replication. Social Psychiatry and Psychiatric Epidemiology, 46(12), 1203–1210. https://doi.org/https://doi.org/10.1007/s00127-010-0296-x
- Steel, C., Schnackenberg, J., Travers, Z., Longden, E., Greenfield, E., Meredith, L., Perry, H., & Corstens, D. (2020). Voice hearers’ experiences of the making sense of voices approach in an NHS setting. Psychosis, 12(2), 106–114. https://doi.org/https://doi.org/10.1080/17522439.2019.1707859
- Weinmann, S., Read, J., & Aderhold, V. (2009). The influence of antipsychotics on mortality in schizophrenia: A systematic review. Schizophrenia Research, 113(1), 1–11.
- Weinmann, S., & Aderhold, V. (2010). Antipsychotic medication, mortality and neurodegeneration. Psychosis, 2(1), 50–269. https://doi.org/https://doi.org/10.1080/17522430903501999
- World Health Organisation (2021). Guidance on community mental health services: Promoting person-centred and rights-based approaches. W.H.O: Geneva.
- Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: Long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70(9), 913–920. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2013.19
- Wykes, T., Evans, J., Paton, C., Barnes, T., Taylor, D., Bentall, R., Dalton, B., Ruffell, T., Rose, D., & Vitoratou, S. (2017). What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication. Psychological Medicine, 47(13), 2369–2378.